BIOPOR.CO Stock — Price, Charts & Analysis

BioPorto A/S (BIOPOR.CO) has no trailing P/E shown and a forward P/E of -20.83x. This places BIOPOR.CO in not enough valuation data territory based on the valuation data currently available on Worldtickers.

BIOPOR.CO trades with -20.83x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether BIOPOR.CO looks overvalued or undervalued.

BIOPOR.CO's P/E of -20.83x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

BIOPOR.CO's trailing EPS is -DKK 0.15 and forward EPS is -DKK 0.06.

EPS, or earnings per share, shows how much profit BioPorto A/S generated for each share. BIOPOR.CO's trailing EPS is -DKK 0.15, and investors usually prefer EPS that is positive and growing over time.

BioPorto A/S has a market cap of DKK 618.87M, making BIOPOR.CO a small-cap stock based on the current market value shown on Worldtickers.

BIOPOR.CO's latest stock price on Worldtickers is DKK 1.25. The latest move is DKK 0.04 or 3.31%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

BIOPOR.CO's quote includes a latest price of DKK 1.25. The market open is DKK 1.22. Previous close is DKK 1.21. The intraday range is DKK 1.21 to DKK 1.26.

BIOPOR.CO is up in the latest quote, with a move of DKK 0.04 or 3.31%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

BIOPOR.CO generated DKK 40.29M in trailing revenue. Revenue growth is 47.20%, which helps show whether demand is expanding or slowing.

BIOPOR.CO's revenue growth is 47.20%, which is a strong demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

No, BIOPOR.CO does not show positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is -DKK 82.12M.

Gross margin is 75.44%. Margins show how efficiently BioPorto A/S turns revenue into profit.

BioPorto A/S carries DKK 7.52M and holds DKK 54.89M in cash.

BIOPOR.CO holds DKK 54.89M on its balance sheet.

BIOPOR.CO's book value per share is DKK 0.13.

Institutions hold 6.28% of BIOPOR.CO shares. Insiders hold 29.80% of shares. Ownership mix helps investors understand how much of BioPorto A/S is held by professional investors and company insiders.

BIOPOR.CO has 495.1M shares outstanding. Float shares are 458.86M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for BIOPOR.CO, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for BIOPOR.CO is -DKK 0.06. Revenue growth is 47.20%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

BIOPOR.CO's trailing EPS is -DKK 0.15. Forward EPS is -DKK 0.06. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

BIOPOR.CO is in the Healthcare sector. Its earnings multiple is -20.83x. Its latest displayed growth metric is 47.20%. Compare these figures with sector peers before deciding whether BioPorto A/S is stronger or weaker than average.

BIOPOR.CO trades at DKK 1.25. The stock trades at -20.83x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of BioPorto A/S's fundamentals.

BIOPOR.CO risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is 1.38, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

BIOPOR.CO should be compared with companies in Diagnostics & Research. Its earnings multiple is -20.83x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

BioPorto A/S (BIOPOR.CO) operates in Healthcare, specifically Diagnostics & Research. BioPorto A/S, an in-vitro diagnostics company, focuses on developing biomarker tests to help clinicians detect the kidney injury in critically ill patients at earlier stage in Denmark, rest of Europe, North America, and Asia. It offers ProNephro AKI (NGAL), a test for pediatric acute kidney injury (AKI); NGAL Test, a particle-enhanced turbidimetric immunoassay for the quantitative determination of neutrophil gelatinase-associated lipocalin (NGAL) in human urine, EDTA plasma, or heparin plasma on automated clinical

BIOPOR.CO trades on Copenhagen. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

BIOPOR.CO stock is priced in DKK on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

BioPorto A/S's official website listed on Worldtickers is www.bioporto.com/investors__1. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

BioPorto A/S employs about 46 people based on the latest company profile data available on Worldtickers. Workforce size helps investors understand company scale and operating complexity.

BioPorto A/S is headquartered in Hellerup, Denmark. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

BIOPOR.CO is in the Healthcare sector and the Diagnostics & Research industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

BIOPOR.CO has traded between DKK 0.84 and DKK 1.49 over the past 52 weeks. At DKK 1.25, it is 15.99% below the high and 48.99% above the low. The 52-week range helps gauge long-term price momentum.

BIOPOR.CO is above both its 50-day and 200-day moving averages, which is a common uptrend signal. Its 50-day moving average is DKK 1.15 and its 200-day moving average is DKK 1.08.

BIOPOR.CO's RSI is 56.23. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

BIOPOR.CO's latest RSI reading is 56.23, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for BIOPOR.CO is near DKK 1.10. Key resistance is near DKK 1.32. Breaks above resistance or below support can change the short-term technical setup.

BIOPOR.CO's nearest reported support level is DKK 1.10. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

BIOPOR.CO's nearest reported resistance level is DKK 1.32. A breakout above resistance can improve momentum, especially when volume confirms the move.

BIOPOR.CO trades about 309.35K shares daily on average. The latest displayed volume is 689.35K shares. Volume helps show liquidity and whether trading interest is unusually high or low.

BIOPOR.CO's MACD is 0.00, which is a positive momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

BIOPOR.CO is above both its 50-day and 200-day moving averages, which is a common uptrend signal. RSI is 56.23 (neutral). MACD is bullish. Nearest support is around DKK 1.10. Resistance is around DKK 1.32. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is DKK 1.19 (2.09% from price). MA50 is DKK 1.15 (5.58% from price). MA200 is DKK 1.08 (12.46% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. BIOPOR.CO's MA20 is DKK 1.19. MA50 is DKK 1.15. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

BIOPOR.CO's pivot is near DKK 1.22. Support is near DKK 1.10. Resistance is near DKK 1.32. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for BIOPOR.CO is near DKK 1.19. The next upper resistance zone is near DKK 1.28. These levels help define risk and possible follow-through zones after a breakout or breakdown.

BIOPOR.CO's Bollinger range is roughly DKK 1.14 to DKK 1.23. Band width is near 8.08%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

BIOPOR.CO's ATR-based typical daily range is about 4.16%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 689.35K shares. Average volume is about 309.35K shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

BIOPOR.CO's all-time high shown on Worldtickers is DKK 20.99. Its all-time low is DKK 0.64. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

BIOPOR.CO has a beta of 1.38, meaning it has historically been more volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.